A randomised comparison of two inactivated hepatitis A vaccines, Avaxim™ and Vaqta™, given as a booster to subjects primed with Avaxim™
- 14 August 2001
- Vol. 19 (31) , 4429-4433
- https://doi.org/10.1016/s0264-410x(01)00195-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccinesVaccine, 2000
- Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccinesJournal of Medical Virology, 2000
- Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A.Journal of Travel Medicine, 1998
- Clinical development of a new inactivated hepatitis a vaccineInfection, 1996
- Duration of protection from clinical hepatitis A disease after vaccination with VAQTA®Journal of Medical Virology, 1996
- VAQTA(TM)Drugs of the Future, 1995
- Protection against hepatitis A by an inactivated vaccineJAMA, 1994
- Sensitive assays for hepatitis a antibodiesJournal of Medical Virology, 1993
- Risk of hepatitis A in travellersVaccine, 1992
- A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy ChildrenNew England Journal of Medicine, 1992